These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 26689114)
21. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634 [TBL] [Abstract][Full Text] [Related]
22. Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada. Singh AE; Gratrix J; Read R; Lovgren M; Drews SJ; Romanowski B; Sutherland K; Talbot J; Martin I Sex Transm Dis; 2013 Sep; 40(9):744-50. PubMed ID: 23945428 [TBL] [Abstract][Full Text] [Related]
23. Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 May; 60(18):579-81. PubMed ID: 21566558 [TBL] [Abstract][Full Text] [Related]
24. [Neisseria gonorrhoeae: antimicrobial resistance and study of population dynamics. Situation in Barcelona in 2011]. Serra-Pladevall J; Barberá-Gracia MJ; Roig-Carbajosa G; Juvé-Saumell R; Gonzalez-Lopez JJ; Bartolomé-Comas R; Andreu-Domingo A Enferm Infecc Microbiol Clin; 2013 Nov; 31(9):579-83. PubMed ID: 23623686 [TBL] [Abstract][Full Text] [Related]
25. The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area. Cole MJ; Quinten C; Jacobsson S; Day M; Amato-Gauci AJ; Woodford N; Spiteri G; Unemo M; BMC Infect Dis; 2019 Dec; 19(1):1040. PubMed ID: 31822275 [TBL] [Abstract][Full Text] [Related]
26. Neisseria gonorrhoeae strain with reduced susceptibilities to extended-spectrum cephalosporins. Nguyen D; Gose S; Castro L; Chung K; Bernstein K; Samuel M; Bauer H; Pandori M Emerg Infect Dis; 2014 Jul; 20(7):1211-3. PubMed ID: 24964277 [TBL] [Abstract][Full Text] [Related]
27. Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia. Whiley DM; Trembizki E; Buckley C; Freeman K; Baird RW; Beaman M; Chen M; Donovan B; Kundu RL; Fairley CK; Guy R; Hogan T; Kaldor JM; Karimi M; Limnios A; Regan DG; Ryder N; Su JY; Ward J; Lahra MM Emerg Infect Dis; 2017 Sep; 23(9):1478-1485. PubMed ID: 28820128 [TBL] [Abstract][Full Text] [Related]
28. Is previous azithromycin treatment associated with azithromycin resistance in Clifton S; Town K; Furegato M; Cole M; Mohammed H; Woodhall SC; Kevin Dunbar J; Fifer H; Hughes G Sex Transm Infect; 2018 Sep; 94(6):421-426. PubMed ID: 29511067 [TBL] [Abstract][Full Text] [Related]
29. Susceptibility of Neisseria gonorrhoeae against a dual treatment antibiotics regimen in primary health centres in Surabaya, Indonesia. Hidayati AN; Sawitri ; Rositawati A; Wardhani PH; Bintanjoyo L Aust J Gen Pract; 2024 Jul; 53(7):499-503. PubMed ID: 38959520 [TBL] [Abstract][Full Text] [Related]
30. Azithromycin in the treatment of infection with Neisseria gonorrhoeae. Bignell C; Garley J Sex Transm Infect; 2010 Nov; 86(6):422-6. PubMed ID: 20940153 [TBL] [Abstract][Full Text] [Related]
31. Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin. Whiley DM; Jennison A; Pearson J; Lahra MM Lancet Infect Dis; 2018 Jul; 18(7):717-718. PubMed ID: 29976521 [No Abstract] [Full Text] [Related]
32. Increases in Neisseria gonorrhoeae With Reduced Susceptibility to Azithromycin Among Men Who Have Sex With Men in Seattle, King County, Washington, 2012-2016. Barbee LA; Soge OO; Katz DA; Dombrowski JC; Holmes KK; Golden MR Clin Infect Dis; 2018 Feb; 66(5):712-718. PubMed ID: 29045604 [TBL] [Abstract][Full Text] [Related]
33. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam. Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520 [TBL] [Abstract][Full Text] [Related]
34. Global resistance of Neisseria gonorrhoeae: when theory becomes reality. Lewis DA Curr Opin Infect Dis; 2014 Feb; 27(1):62-7. PubMed ID: 24275696 [TBL] [Abstract][Full Text] [Related]
35. The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting. Whiley DM; Goire N; Lahra MM; Donovan B; Limnios AE; Nissen MD; Sloots TP J Antimicrob Chemother; 2012 Sep; 67(9):2059-61. PubMed ID: 22604449 [TBL] [Abstract][Full Text] [Related]
36. Antimicrobial susceptibility and molecular epidemiology of Neisseria gonorrhoeae in Germany. Horn NN; Kresken M; Körber-Irrgang B; Göttig S; Wichelhaus C; Wichelhaus TA; Int J Med Microbiol; 2014 Jul; 304(5-6):586-91. PubMed ID: 24801146 [TBL] [Abstract][Full Text] [Related]
37. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Ison CA; Hussey J; Sankar KN; Evans J; Alexander S Euro Surveill; 2011 Apr; 16(14):. PubMed ID: 21492528 [TBL] [Abstract][Full Text] [Related]
38. Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000-2009. Martin I; Jayaraman G; Wong T; Liu G; Gilmour M; Sex Transm Dis; 2011 Oct; 38(10):892-8. PubMed ID: 21934558 [TBL] [Abstract][Full Text] [Related]